FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is a group of inventions concerning a new application of bicyclo[2,2,2]octane-2-carboxylic acid salt. What is presented is using it for treating dysphoria in a person suffering epilepsy for treating alcohol addiction, for reducing the level of hepatic function marker specified in AST (aspartate aminotransferase), ALT (alanine aminotransferase) or bilirubin in the person for reducing an erythrocyte sedimentation rate, as well as for reducing a number or an intensity of epileptic attacks in a daily dose of min 400 mg.
EFFECT: implementing the above applications with no negative effect on patient's behaviour and the functions of the main organs and systems.
19 cl, 6 tbl, 2 ex
Authors
Dates
2015-04-10—Published
2009-12-21—Filed